| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.68B | 79.72B | 63.33B | 59.86B | 58.66B | 50.33B |
| Gross Profit | 32.51B | 32.08B | 25.43B | 22.44B | 20.50B | 16.42B |
| EBITDA | 13.72B | 12.16B | 9.93B | 9.57B | 9.60B | 6.90B |
| Net Income | 6.30B | 5.94B | 5.15B | 5.14B | 5.37B | 3.62B |
Balance Sheet | ||||||
| Total Assets | 87.91B | 79.22B | 60.83B | 56.64B | 57.09B | 48.30B |
| Cash, Cash Equivalents and Short-Term Investments | 4.09B | 2.29B | 2.08B | 2.11B | 2.14B | 2.04B |
| Total Debt | 33.25B | 25.69B | 15.33B | 13.93B | 17.84B | 11.94B |
| Total Liabilities | 42.95B | 38.24B | 23.82B | 22.97B | 26.75B | 20.30B |
| Stockholders Equity | 44.96B | 40.98B | 37.00B | 33.67B | 30.33B | 27.99B |
Cash Flow | ||||||
| Free Cash Flow | 10.02B | 4.60B | 5.60B | 7.41B | 6.19B | 8.02B |
| Operating Cash Flow | 11.78B | 7.01B | 6.45B | 7.95B | 7.04B | 9.76B |
| Investing Cash Flow | -4.62B | -7.46B | -579.93M | 163.53M | -5.95B | -3.50B |
| Financing Cash Flow | -5.71B | 225.92M | -5.64B | -7.43B | -1.58B | -6.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹188.57B | 36.53 | ― | 1.32% | 7.29% | 0.32% | |
70 Outperform | ₹74.55B | 18.01 | ― | 0.94% | 8.65% | 13.08% | |
69 Neutral | ₹139.19B | 28.61 | ― | 0.02% | 20.84% | 30.79% | |
62 Neutral | ₹149.16B | 48.02 | ― | 1.13% | 21.97% | 10.85% | |
60 Neutral | ₹103.97B | 47.77 | ― | 0.79% | 30.48% | 20.51% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
55 Neutral | ₹19.13B | 12.17 | ― | 1.51% | 0.97% | -78.30% |